- American Airlines: Goldman Sachs downgrades. to sell from neutral. PT down 16% to $18
- Biogen : Wedbush adjusts price target to $297 from $314, maintains neutral rating
- Biohaven Pharmaceutical: Wedbush adjusts price target to $152 from $128, maintains outperform rating
- Capital One Financial: Autonomous Research adjusts price target for capital one financial to $190 from $185, maintains outperform rating
- CDW: Morgan Stanley cut the recommendation to equal-weight from overweight. PT up 6.4% to $196
- Citigroup: Goldman Sachs adjusts price target to $82 from $78, maintains buy rating
- Cleveland-Cliffs: Goldman Sachs raised the recommendation to buy from neutral. PT up 16% to $24
- Commercial Metals: Goldman Sachs raised its recommendation to neutral from sell. PT up 3.9% to $33
- Gogo: Morgan Stanley downgrades to underweight from equal-weight. PT down 18% to $14
- Hiscox: Jefferies remains at Hold with a price target reduced from GBP 950 to GBP 925.
- HSBC Holdings: UBS upgrades its rating from Neutral to Buy. Previously set at GBp 450, the target price has been raised to GBp 485.
- JetBlue: Goldman Sachs downgrades to neutral from buy. PT up 5.5% to $17
- Morgan Stanley: Goldman Sachs adjusts price target to $113 from $108, maintains buy rating
- Nucor: Goldman Sachs downgrades to neutral from buy. PT up 9.4% to $108
- Phillips 66: Piper Sandler raised the recommendation to overweight from neutral. PT up 12% to $87
- Rio Tinto: Exane BNP Paribas upgrades from neutral to outperform targeting GBp 5,630.
- Rolls-Royce: Bernstein upgrades from Underperform to Market Perform targeting GBp 133.
- Secure Income: Germany Sachs downgrades from buy to neutral with a target of GBp 450.
- SVB Financial: Autonomous Research adjusts price target to $700 from $625, maintains neutral rating
- United States Steel: Goldman Sachs cut the recommendation to sell from neutral. PT down 6.4% to $21.